Norway
Duty free*
- Their lines2 Norwegian lines
30.04.9002 Containing narcotic drugs or psychotropic substances
Norwegian tariff data checked Sept. 13, 2026.
Customs code · HS subheading 3004 90
Final code reached
Dosed or retail-packaged therapeutic or preventive medicines
Excluding specified ingredients
This is a complete 8-digit customs code. Exports and Intrastat use it as it is. For an import into the EU the declaration uses 3004 90 00 00: this code with 00 added.
This covers medicines made from mixed or unmixed products for therapeutic or preventive use, when they are dosed, including transdermal products, or presented in forms or packaging for retail sale. It excludes medicines containing antibiotics, hormones or hormone-used steroids, alkaloids, provitamins, vitamins or their derivatives, specified malaria-active ingredients, and sets for clinical blind trials.
See the official tariff text
Official tariff text
Medicaments consisting of mixed or unmixed products for therapeutic or prophylactic purposes, put up in measured doses "incl. those for transdermal administration" or in forms or packings for retail sale (excl. containing antibiotics, hormones or steroids used as hormones, alkaloids, provitamins, vitamins, their derivatives, antimalarial active principles and blinded clinical trial kits)
You are seeing what applies when you export from the EU. Switch above if you import.
You are seeing what applies when you import into the EU. Switch above if you export.
Your answer for export
The full EU export code is 3004 90 00.
You do not pick a 10-digit EU import line for an export declaration or Intrastat. The destination classifies the goods under its own tariff.
8 digits, ready
Selling to Norway, Great Britain and the United States
What they charge on arrival.
Norway, Great Britain and the United States use their own tariff lines under the 6-digit HS code. The rates below are what their customs charge on goods arriving from the EU. Match the goods against each country's own wording before you rely on a rate.
Great Britain
Duty free*
- Their lines1 British line
3004 90 00 00 Other
Northern Ireland follows other rules.
UK tariff data checked Sept. 13, 2026.
United States
0.0% or 15.0%†
Depends on a question
- Their lines75 US lines
- Entry dateSept. 17, 2026
3004.90.10.00 Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed
The US importer of record files the entry.
US tariff data checked Sept. 16, 2026.
See the 2 Norwegian lines
Selling to Norway
Norway splits the 6-digit category its own way, so these are Norway's own lines under it, not this EU code. Check your product against their wording; what Norwegian customs charges is shown per line.
-
30.04.9002
Containing narcotic drugs or psychotropic substances
- Ordinary duty
- Duty free*
-
30.04.9008
Other
- Ordinary duty
- Duty free*
Contains data from Norwegian Customs (data.toll.no), licensed under CC BY 4.0, adapted for display.
See the 1 British line
Selling to Great Britain
What UK customs charges when goods like these arrive in Great Britain.
-
3004 90 00 00
Other
- Ordinary duty
- Duty free*
These rates apply in Great Britain. Different rules may apply for goods entering Northern Ireland.
Contains public sector information licensed under the Open Government Licence v3.0.
Source: UK Department for Business and Trade (data.api.trade.gov.uk).
See the 75 US lines
Selling to the United States
What US customs charges when goods like these arrive from the EU. The US importer of record files the entry and pays the duty.
-
3004.90.10.00
Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Containing antigens or hyaluronic acid or its sodium salt
- General rate
- Free
- From the EU
- 0.0% or 15.0%† Depends on a question US headings applied: 9903.04.62, 9903.05.86 Section 232 pharmaceuticals, Proclamation 11020 of 2 April 2026 (91 FR 18183) clauses (3)(c), (4), (5) and (7), heading 9903.04.62 of subchapter III of chapter 99 with U.S. note 40(c) and (f): the rate for patented pharmaceuticals and associated ingredients shall be 15 percent for products of the European Union, the sum of the column 1 duty rate and the additional duty being that rate; generic pharmaceuticals are not subject to tariffs pursuant to section 232 at this time; effective 31 July 2026 for the companies listed in Annex III and 29 September 2026 for other companiesU.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
-
3004.90.92.01
Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, For veterinary use
- General rate
- Free
- From the EU
- 0.0% or 15.0%† Depends on a question US headings applied: 9903.04.62, 9903.05.86 Section 232 pharmaceuticals, Proclamation 11020 of 2 April 2026 (91 FR 18183) clauses (3)(c), (4), (5) and (7), heading 9903.04.62 of subchapter III of chapter 99 with U.S. note 40(c) and (f): the rate for patented pharmaceuticals and associated ingredients shall be 15 percent for products of the European Union, the sum of the column 1 duty rate and the additional duty being that rate; generic pharmaceuticals are not subject to tariffs pursuant to section 232 at this time; effective 31 July 2026 for the companies listed in Annex III and 29 September 2026 for other companiesU.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
-
3004.90.92.03
Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Anti-infective medicaments, Antivirals, Containing acyclovir or its salts
- General rate
- Free
- From the EU
- 0.0%† Estimated from published US measures US headings applied: 9903.05.86 U.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
-
3004.90.92.04
Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Anti-infective medicaments, Antivirals, Containing oseltamivir or its salts
- General rate
- Free
- From the EU
- 0.0%† Estimated from published US measures US headings applied: 9903.05.86 U.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
-
3004.90.92.05
Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Anti-infective medicaments, Antivirals, Containing valganciclovir, peramivir or their salts
- General rate
- Free
- From the EU
- 0.0%† Estimated from published US measures US headings applied: 9903.05.86 U.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
-
3004.90.92.06
Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Anti-infective medicaments, Antivirals, Other
- General rate
- Free
- From the EU
- 0.0% or 15.0%† Depends on a question US headings applied: 9903.04.62, 9903.05.86 Section 232 pharmaceuticals, Proclamation 11020 of 2 April 2026 (91 FR 18183) clauses (3)(c), (4), (5) and (7), heading 9903.04.62 of subchapter III of chapter 99 with U.S. note 40(c) and (f): the rate for patented pharmaceuticals and associated ingredients shall be 15 percent for products of the European Union, the sum of the column 1 duty rate and the additional duty being that rate; generic pharmaceuticals are not subject to tariffs pursuant to section 232 at this time; effective 31 July 2026 for the companies listed in Annex III and 29 September 2026 for other companiesU.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
-
3004.90.92.07
Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Anti-infective medicaments, Antifungals, Containing fluconazole or its salts
- General rate
- Free
- From the EU
- 0.0%† Estimated from published US measures US headings applied: 9903.05.86 U.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
-
3004.90.92.08
Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Anti-infective medicaments, Antifungals, Other
- General rate
- Free
- From the EU
- 0.0% or 15.0%† Depends on a question US headings applied: 9903.04.62, 9903.05.86 Section 232 pharmaceuticals, Proclamation 11020 of 2 April 2026 (91 FR 18183) clauses (3)(c), (4), (5) and (7), heading 9903.04.62 of subchapter III of chapter 99 with U.S. note 40(c) and (f): the rate for patented pharmaceuticals and associated ingredients shall be 15 percent for products of the European Union, the sum of the column 1 duty rate and the additional duty being that rate; generic pharmaceuticals are not subject to tariffs pursuant to section 232 at this time; effective 31 July 2026 for the companies listed in Annex III and 29 September 2026 for other companiesU.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
Show all 75 lines
-
3004.90.92.09
Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Anti-infective medicaments, Antiprotozoals (excluding goods described in subheading note 2 to this chapter), Containing metronidazole or its salts
- General rate
- Free
- From the EU
- 0.0%† Estimated from published US measures US headings applied: 9903.05.86 U.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
-
3004.90.92.10
Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Anti-infective medicaments, Antiprotozoals (excluding goods described in subheading note 2 to this chapter), Other
- General rate
- Free
- From the EU
- 0.0% or 15.0%† Depends on a question US headings applied: 9903.04.62, 9903.05.86 Section 232 pharmaceuticals, Proclamation 11020 of 2 April 2026 (91 FR 18183) clauses (3)(c), (4), (5) and (7), heading 9903.04.62 of subchapter III of chapter 99 with U.S. note 40(c) and (f): the rate for patented pharmaceuticals and associated ingredients shall be 15 percent for products of the European Union, the sum of the column 1 duty rate and the additional duty being that rate; generic pharmaceuticals are not subject to tariffs pursuant to section 232 at this time; effective 31 July 2026 for the companies listed in Annex III and 29 September 2026 for other companiesU.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
-
3004.90.92.11
Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Anti-infective medicaments, Sulfonamides, Containing trimethoprim and sulfamethoxazole or their salts
- General rate
- Free
- From the EU
- 0.0% or 15.0%† Depends on a question US headings applied: 9903.04.62, 9903.05.86 Section 232 pharmaceuticals, Proclamation 11020 of 2 April 2026 (91 FR 18183) clauses (3)(c), (4), (5) and (7), heading 9903.04.62 of subchapter III of chapter 99 with U.S. note 40(c) and (f): the rate for patented pharmaceuticals and associated ingredients shall be 15 percent for products of the European Union, the sum of the column 1 duty rate and the additional duty being that rate; generic pharmaceuticals are not subject to tariffs pursuant to section 232 at this time; effective 31 July 2026 for the companies listed in Annex III and 29 September 2026 for other companiesU.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
-
3004.90.92.12
Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Anti-infective medicaments, Sulfonamides, Other
- General rate
- Free
- From the EU
- 0.0%† Estimated from published US measures US headings applied: 9903.05.86 U.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
-
3004.90.92.13
Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Anti-infective medicaments, Other, Containing levofloxacin or its salts
- General rate
- Free
- From the EU
- 0.0%† Estimated from published US measures US headings applied: 9903.05.86 U.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
-
3004.90.92.14
Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Anti-infective medicaments, Other, Containing linezolid or its salts
- General rate
- Free
- From the EU
- 0.0%† Estimated from published US measures US headings applied: 9903.05.86 U.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
-
3004.90.92.15
Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Anti-infective medicaments, Other
- General rate
- Free
- From the EU
- 0.0% or 15.0%† Depends on a question US headings applied: 9903.04.62, 9903.05.86 Section 232 pharmaceuticals, Proclamation 11020 of 2 April 2026 (91 FR 18183) clauses (3)(c), (4), (5) and (7), heading 9903.04.62 of subchapter III of chapter 99 with U.S. note 40(c) and (f): the rate for patented pharmaceuticals and associated ingredients shall be 15 percent for products of the European Union, the sum of the column 1 duty rate and the additional duty being that rate; generic pharmaceuticals are not subject to tariffs pursuant to section 232 at this time; effective 31 July 2026 for the companies listed in Annex III and 29 September 2026 for other companiesU.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
-
3004.90.92.16
Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Antineoplastic and immunosuppressive medicaments, Containing hydroxyurea or cyclophosphamide or their salts
- General rate
- Free
- From the EU
- 0.0% or 15.0%† Depends on a question US headings applied: 9903.04.62, 9903.05.86 Section 232 pharmaceuticals, Proclamation 11020 of 2 April 2026 (91 FR 18183) clauses (3)(c), (4), (5) and (7), heading 9903.04.62 of subchapter III of chapter 99 with U.S. note 40(c) and (f): the rate for patented pharmaceuticals and associated ingredients shall be 15 percent for products of the European Union, the sum of the column 1 duty rate and the additional duty being that rate; generic pharmaceuticals are not subject to tariffs pursuant to section 232 at this time; effective 31 July 2026 for the companies listed in Annex III and 29 September 2026 for other companiesU.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
-
3004.90.92.17
Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Antineoplastic and immunosuppressive medicaments, Containing tacrolimus or mycophenolate mofetil or its salts
- General rate
- Free
- From the EU
- 0.0%† Estimated from published US measures US headings applied: 9903.05.86 U.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
-
3004.90.92.18
Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Antineoplastic and immunosuppressive medicaments, Other
- General rate
- Free
- From the EU
- 0.0%† Estimated from published US measures US headings applied: 9903.05.86 U.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
-
3004.90.92.19
Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Cardiovascular medicaments, Containing metoprolol or its salts
- General rate
- Free
- From the EU
- 0.0%† Estimated from published US measures US headings applied: 9903.05.86 U.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
-
3004.90.92.20
Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Cardiovascular medicaments, Containing amiodarone or its salts
- General rate
- Free
- From the EU
- 0.0%† Estimated from published US measures US headings applied: 9903.05.86 U.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
-
3004.90.92.21
Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Cardiovascular medicaments, Containing diltiazem or its salts
- General rate
- Free
- From the EU
- 0.0%† Estimated from published US measures US headings applied: 9903.05.86 U.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
-
3004.90.92.22
Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Cardiovascular medicaments, Containing hydralazine or its salts
- General rate
- Free
- From the EU
- 0.0%† Estimated from published US measures US headings applied: 9903.05.86 U.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
-
3004.90.92.23
Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Cardiovascular medicaments, Containing enoxaparin or its salts
- General rate
- Free
- From the EU
- 0.0%† Estimated from published US measures US headings applied: 9903.05.86 U.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
-
3004.90.92.24
Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Cardiovascular medicaments, Containing labetalol or its salts
- General rate
- Free
- From the EU
- 0.0%† Estimated from published US measures US headings applied: 9903.05.86 U.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
-
3004.90.92.25
Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Cardiovascular medicaments, Containing argatroban, adenosine, amlodipine, esmolol, dobutamine, phenoxybenzamine or their salts
- General rate
- Free
- From the EU
- 0.0% or 15.0%† Depends on a question US headings applied: 9903.04.62, 9903.05.86 Section 232 pharmaceuticals, Proclamation 11020 of 2 April 2026 (91 FR 18183) clauses (3)(c), (4), (5) and (7), heading 9903.04.62 of subchapter III of chapter 99 with U.S. note 40(c) and (f): the rate for patented pharmaceuticals and associated ingredients shall be 15 percent for products of the European Union, the sum of the column 1 duty rate and the additional duty being that rate; generic pharmaceuticals are not subject to tariffs pursuant to section 232 at this time; effective 31 July 2026 for the companies listed in Annex III and 29 September 2026 for other companiesU.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
-
3004.90.92.26
Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Cardiovascular medicaments, Other
- General rate
- Free
- From the EU
- 0.0%† Estimated from published US measures US headings applied: 9903.05.86 U.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
-
3004.90.92.27
Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Medicaments primarily affecting the central nervous system, Analgesics, antipyretics and nonhormonal anti-inflammatory agents, Tolmetin
- General rate
- Free
- From the EU
- 0.0%† Estimated from published US measures US headings applied: 9903.05.86 U.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
-
3004.90.92.28
Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Medicaments primarily affecting the central nervous system, Analgesics, antipyretics and nonhormonal anti-inflammatory agents, Tolmetin sodium dihydrate
- General rate
- Free
- From the EU
- 0.0%† Estimated from published US measures US headings applied: 9903.05.86 U.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
-
3004.90.92.29
Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Medicaments primarily affecting the central nervous system, Analgesics, antipyretics and nonhormonal anti-inflammatory agents, Tolmetin sodium (anhydrous)
- General rate
- Free
- From the EU
- 0.0%† Estimated from published US measures US headings applied: 9903.05.86 U.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
-
3004.90.92.30
Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Medicaments primarily affecting the central nervous system, Analgesics, antipyretics and nonhormonal anti-inflammatory agents, Containing ibuprofen or its salts, For oral suspension
- General rate
- Free
- From the EU
- 0.0%† Estimated from published US measures US headings applied: 9903.05.86 U.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
-
3004.90.92.31
Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Medicaments primarily affecting the central nervous system, Analgesics, antipyretics and nonhormonal anti-inflammatory agents, Containing ibuprofen or its salts, Other
- General rate
- Free
- From the EU
- 0.0%† Estimated from published US measures US headings applied: 9903.05.86 U.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
-
3004.90.92.32
Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Medicaments primarily affecting the central nervous system, Analgesics, antipyretics and nonhormonal anti-inflammatory agents, Containing acetaminophen or its salts, For oral suspension
- General rate
- Free
- From the EU
- 0.0%† Estimated from published US measures US headings applied: 9903.05.86 U.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
-
3004.90.92.33
Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Medicaments primarily affecting the central nervous system, Analgesics, antipyretics and nonhormonal anti-inflammatory agents, Containing acetaminophen or its salts, Other
- General rate
- Free
- From the EU
- 0.0%† Estimated from published US measures US headings applied: 9903.05.86 U.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
-
3004.90.92.34
Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Medicaments primarily affecting the central nervous system, Analgesics, antipyretics and nonhormonal anti-inflammatory agents, Containing O-Acetylsalicylic acid (Aspirin)
- General rate
- Free
- From the EU
- 0.0%† Estimated from published US measures US headings applied: 9903.05.86 U.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
-
3004.90.92.35
Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Medicaments primarily affecting the central nervous system, Analgesics, antipyretics and nonhormonal anti-inflammatory agents, Containing tramadol
- General rate
- Free
- From the EU
- 0.0%† Estimated from published US measures US headings applied: 9903.05.86 U.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
-
3004.90.92.36
Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Medicaments primarily affecting the central nervous system, Analgesics, antipyretics and nonhormonal anti-inflammatory agents, Other
- General rate
- Free
- From the EU
- 0.0% or 15.0%† Depends on a question US headings applied: 9903.04.62, 9903.05.86 Section 232 pharmaceuticals, Proclamation 11020 of 2 April 2026 (91 FR 18183) clauses (3)(c), (4), (5) and (7), heading 9903.04.62 of subchapter III of chapter 99 with U.S. note 40(c) and (f): the rate for patented pharmaceuticals and associated ingredients shall be 15 percent for products of the European Union, the sum of the column 1 duty rate and the additional duty being that rate; generic pharmaceuticals are not subject to tariffs pursuant to section 232 at this time; effective 31 July 2026 for the companies listed in Annex III and 29 September 2026 for other companiesU.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
-
3004.90.92.37
Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Medicaments primarily affecting the central nervous system, Anticonvulsants, hypnotics and sedatives, Containing dexmedetomidine, etomidate, midazolam, propofol or their salts
- General rate
- Free
- From the EU
- 0.0%† Estimated from published US measures US headings applied: 9903.05.86 U.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
-
3004.90.92.38
Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Medicaments primarily affecting the central nervous system, Anticonvulsants, hypnotics and sedatives, Containing midazolam or its salts
- General rate
- Free
- From the EU
- 0.0%† Estimated from published US measures US headings applied: 9903.05.86 U.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
-
3004.90.92.39
Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Medicaments primarily affecting the central nervous system, Anticonvulsants, hypnotics and sedatives, Containing phenytoin or its salts
- General rate
- Free
- From the EU
- 0.0%† Estimated from published US measures US headings applied: 9903.05.86 U.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
-
3004.90.92.40
Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Medicaments primarily affecting the central nervous system, Anticonvulsants, hypnotics and sedatives, Containing propofol or its salts
- General rate
- Free
- From the EU
- 0.0%† Estimated from published US measures US headings applied: 9903.05.86 U.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
-
3004.90.92.41
Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Medicaments primarily affecting the central nervous system, Anticonvulsants, hypnotics and sedatives, Containing levetiracetam, phenytoin or their salts
- General rate
- Free
- From the EU
- 0.0%† Estimated from published US measures US headings applied: 9903.05.86 U.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
-
3004.90.92.42
Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Medicaments primarily affecting the central nervous system, Anticonvulsants, hypnotics and sedatives, Containing etomidate or its salts
- General rate
- Free
- From the EU
- 0.0%† Estimated from published US measures US headings applied: 9903.05.86 U.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
-
3004.90.92.43
Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Medicaments primarily affecting the central nervous system, Anticonvulsants, hypnotics and sedatives, Other
- General rate
- Free
- From the EU
- 0.0% or 15.0%† Depends on a question US headings applied: 9903.04.62, 9903.05.86 Section 232 pharmaceuticals, Proclamation 11020 of 2 April 2026 (91 FR 18183) clauses (3)(c), (4), (5) and (7), heading 9903.04.62 of subchapter III of chapter 99 with U.S. note 40(c) and (f): the rate for patented pharmaceuticals and associated ingredients shall be 15 percent for products of the European Union, the sum of the column 1 duty rate and the additional duty being that rate; generic pharmaceuticals are not subject to tariffs pursuant to section 232 at this time; effective 31 July 2026 for the companies listed in Annex III and 29 September 2026 for other companiesU.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
-
3004.90.92.44
Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Medicaments primarily affecting the central nervous system, Antidepressants, tranquilizers, and other psychotherapeutic agents, Containing lorazepam or its salts
- General rate
- Free
- From the EU
- 0.0%† Estimated from published US measures US headings applied: 9903.05.86 U.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
-
3004.90.92.45
Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Medicaments primarily affecting the central nervous system, Antidepressants, tranquilizers, and other psychotherapeutic agents, Containing olanzapine or its salts
- General rate
- Free
- From the EU
- 0.0%† Estimated from published US measures US headings applied: 9903.05.86 U.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
-
3004.90.92.46
Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Medicaments primarily affecting the central nervous system, Antidepressants, tranquilizers, and other psychotherapeutic agents, Other
- General rate
- Free
- From the EU
- 0.0% or 15.0%† Depends on a question US headings applied: 9903.04.62, 9903.05.86 Section 232 pharmaceuticals, Proclamation 11020 of 2 April 2026 (91 FR 18183) clauses (3)(c), (4), (5) and (7), heading 9903.04.62 of subchapter III of chapter 99 with U.S. note 40(c) and (f): the rate for patented pharmaceuticals and associated ingredients shall be 15 percent for products of the European Union, the sum of the column 1 duty rate and the additional duty being that rate; generic pharmaceuticals are not subject to tariffs pursuant to section 232 at this time; effective 31 July 2026 for the companies listed in Annex III and 29 September 2026 for other companiesU.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
-
3004.90.92.47
Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Medicaments primarily affecting the central nervous system, Other, Containing rocuronium or its salts
- General rate
- Free
- From the EU
- 0.0%† Estimated from published US measures US headings applied: 9903.05.86 U.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
-
3004.90.92.48
Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Medicaments primarily affecting the central nervous system, Other, Containing succinylcholine or its salts
- General rate
- Free
- From the EU
- 0.0%† Estimated from published US measures US headings applied: 9903.05.86 U.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
-
3004.90.92.49
Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Medicaments primarily affecting the central nervous system, Other
- General rate
- Free
- From the EU
- 0.0% or 15.0%† Depends on a question US headings applied: 9903.04.62, 9903.05.86 Section 232 pharmaceuticals, Proclamation 11020 of 2 April 2026 (91 FR 18183) clauses (3)(c), (4), (5) and (7), heading 9903.04.62 of subchapter III of chapter 99 with U.S. note 40(c) and (f): the rate for patented pharmaceuticals and associated ingredients shall be 15 percent for products of the European Union, the sum of the column 1 duty rate and the additional duty being that rate; generic pharmaceuticals are not subject to tariffs pursuant to section 232 at this time; effective 31 July 2026 for the companies listed in Annex III and 29 September 2026 for other companiesU.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
-
3004.90.92.50
Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Dermatological agents and local anesthetics, Containing lidocaine or its salts
- General rate
- Free
- From the EU
- 0.0%† Estimated from published US measures US headings applied: 9903.05.86 U.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
-
3004.90.92.51
Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Dermatological agents and local anesthetics, Other
- General rate
- Free
- From the EU
- 0.0% or 15.0%† Depends on a question US headings applied: 9903.04.62, 9903.05.86 Section 232 pharmaceuticals, Proclamation 11020 of 2 April 2026 (91 FR 18183) clauses (3)(c), (4), (5) and (7), heading 9903.04.62 of subchapter III of chapter 99 with U.S. note 40(c) and (f): the rate for patented pharmaceuticals and associated ingredients shall be 15 percent for products of the European Union, the sum of the column 1 duty rate and the additional duty being that rate; generic pharmaceuticals are not subject to tariffs pursuant to section 232 at this time; effective 31 July 2026 for the companies listed in Annex III and 29 September 2026 for other companiesU.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
-
3004.90.92.52
Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Medicaments primarily affecting the digestive system, Laxatives
- General rate
- Free
- From the EU
- 0.0% or 15.0%† Depends on a question US headings applied: 9903.04.62, 9903.05.86 Section 232 pharmaceuticals, Proclamation 11020 of 2 April 2026 (91 FR 18183) clauses (3)(c), (4), (5) and (7), heading 9903.04.62 of subchapter III of chapter 99 with U.S. note 40(c) and (f): the rate for patented pharmaceuticals and associated ingredients shall be 15 percent for products of the European Union, the sum of the column 1 duty rate and the additional duty being that rate; generic pharmaceuticals are not subject to tariffs pursuant to section 232 at this time; effective 31 July 2026 for the companies listed in Annex III and 29 September 2026 for other companiesU.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
-
3004.90.92.53
Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Medicaments primarily affecting the digestive system, Antacids
- General rate
- Free
- From the EU
- 0.0% or 15.0%† Depends on a question US headings applied: 9903.04.62, 9903.05.86 Section 232 pharmaceuticals, Proclamation 11020 of 2 April 2026 (91 FR 18183) clauses (3)(c), (4), (5) and (7), heading 9903.04.62 of subchapter III of chapter 99 with U.S. note 40(c) and (f): the rate for patented pharmaceuticals and associated ingredients shall be 15 percent for products of the European Union, the sum of the column 1 duty rate and the additional duty being that rate; generic pharmaceuticals are not subject to tariffs pursuant to section 232 at this time; effective 31 July 2026 for the companies listed in Annex III and 29 September 2026 for other companiesU.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
-
3004.90.92.54
Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Medicaments primarily affecting the digestive system, Containing famotidine or its salts
- General rate
- Free
- From the EU
- 0.0%† Estimated from published US measures US headings applied: 9903.05.86 U.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
-
3004.90.92.55
Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Medicaments primarily affecting the digestive system, Containing pantoprazole or its salts
- General rate
- Free
- From the EU
- 0.0%† Estimated from published US measures US headings applied: 9903.05.86 U.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
-
3004.90.92.56
Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Medicaments primarily affecting the digestive system, Containing ondansetron or its salts
- General rate
- Free
- From the EU
- 0.0%† Estimated from published US measures US headings applied: 9903.05.86 U.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
-
3004.90.92.57
Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Medicaments primarily affecting the digestive system, Containing glycopyrrolate or its salts
- General rate
- Free
- From the EU
- 0.0%† Estimated from published US measures US headings applied: 9903.05.86 U.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
-
3004.90.92.58
Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Medicaments primarily affecting the digestive system, Containing loperamide or its salts
- General rate
- Free
- From the EU
- 0.0%† Estimated from published US measures US headings applied: 9903.05.86 U.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
-
3004.90.92.60
Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Medicaments primarily affecting the digestive system, Other
- General rate
- Free
- From the EU
- 0.0% or 15.0%† Depends on a question US headings applied: 9903.04.62, 9903.05.86 Section 232 pharmaceuticals, Proclamation 11020 of 2 April 2026 (91 FR 18183) clauses (3)(c), (4), (5) and (7), heading 9903.04.62 of subchapter III of chapter 99 with U.S. note 40(c) and (f): the rate for patented pharmaceuticals and associated ingredients shall be 15 percent for products of the European Union, the sum of the column 1 duty rate and the additional duty being that rate; generic pharmaceuticals are not subject to tariffs pursuant to section 232 at this time; effective 31 July 2026 for the companies listed in Annex III and 29 September 2026 for other companiesU.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
-
3004.90.92.61
Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Preparations primarily affecting the electrolytic, caloric or water balance, Diuretics, Containing furosemide and its salts
- General rate
- Free
- From the EU
- 0.0%† Estimated from published US measures US headings applied: 9903.05.86 U.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
-
3004.90.92.62
Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Preparations primarily affecting the electrolytic, caloric or water balance, Diuretics, Containing hydrochlorothiazide or its salts
- General rate
- Free
- From the EU
- 0.0%† Estimated from published US measures US headings applied: 9903.05.86 U.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
-
3004.90.92.63
Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Preparations primarily affecting the electrolytic, caloric or water balance, Diuretics, Other
- General rate
- Free
- From the EU
- 0.0% or 15.0%† Depends on a question US headings applied: 9903.04.62, 9903.05.86 Section 232 pharmaceuticals, Proclamation 11020 of 2 April 2026 (91 FR 18183) clauses (3)(c), (4), (5) and (7), heading 9903.04.62 of subchapter III of chapter 99 with U.S. note 40(c) and (f): the rate for patented pharmaceuticals and associated ingredients shall be 15 percent for products of the European Union, the sum of the column 1 duty rate and the additional duty being that rate; generic pharmaceuticals are not subject to tariffs pursuant to section 232 at this time; effective 31 July 2026 for the companies listed in Annex III and 29 September 2026 for other companiesU.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
-
3004.90.92.64
Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Preparations primarily affecting the electrolytic, caloric or water balance, Other, Containing calcium gluconate
- General rate
- Free
- From the EU
- 0.0%† Estimated from published US measures US headings applied: 9903.05.86 U.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
-
3004.90.92.65
Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Preparations primarily affecting the electrolytic, caloric or water balance, Other, Containing potassium chloride
- General rate
- Free
- From the EU
- 0.0%† Estimated from published US measures US headings applied: 9903.05.86 U.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
-
3004.90.92.66
Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Preparations primarily affecting the electrolytic, caloric or water balance, Other, Containing sodium bicarbonate, in injection form
- General rate
- Free
- From the EU
- 0.0%† Estimated from published US measures US headings applied: 9903.05.86 U.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
-
3004.90.92.67
Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Preparations primarily affecting the electrolytic, caloric or water balance, Other
- General rate
- Free
- From the EU
- 0.0% or 15.0%† Depends on a question US headings applied: 9903.04.62, 9903.05.86 Section 232 pharmaceuticals, Proclamation 11020 of 2 April 2026 (91 FR 18183) clauses (3)(c), (4), (5) and (7), heading 9903.04.62 of subchapter III of chapter 99 with U.S. note 40(c) and (f): the rate for patented pharmaceuticals and associated ingredients shall be 15 percent for products of the European Union, the sum of the column 1 duty rate and the additional duty being that rate; generic pharmaceuticals are not subject to tariffs pursuant to section 232 at this time; effective 31 July 2026 for the companies listed in Annex III and 29 September 2026 for other companiesU.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
-
3004.90.92.68
Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Medicaments primarily affecting the eyes, ears, or respiratory system, Cough and cold preparations
- General rate
- Free
- From the EU
- 0.0% or 15.0%† Depends on a question US headings applied: 9903.04.62, 9903.05.86 Section 232 pharmaceuticals, Proclamation 11020 of 2 April 2026 (91 FR 18183) clauses (3)(c), (4), (5) and (7), heading 9903.04.62 of subchapter III of chapter 99 with U.S. note 40(c) and (f): the rate for patented pharmaceuticals and associated ingredients shall be 15 percent for products of the European Union, the sum of the column 1 duty rate and the additional duty being that rate; generic pharmaceuticals are not subject to tariffs pursuant to section 232 at this time; effective 31 July 2026 for the companies listed in Annex III and 29 September 2026 for other companiesU.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
-
3004.90.92.69
Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Medicaments primarily affecting the eyes, ears, or respiratory system, Other, Antihistamines, Containing diphenhydramine or its salts
- General rate
- Free
- From the EU
- 0.0%† Estimated from published US measures US headings applied: 9903.05.86 U.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
-
3004.90.92.70
Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Medicaments primarily affecting the eyes, ears, or respiratory system, Other, Antihistamines, Other
- General rate
- Free
- From the EU
- 0.0% or 15.0%† Depends on a question US headings applied: 9903.04.62, 9903.05.86 Section 232 pharmaceuticals, Proclamation 11020 of 2 April 2026 (91 FR 18183) clauses (3)(c), (4), (5) and (7), heading 9903.04.62 of subchapter III of chapter 99 with U.S. note 40(c) and (f): the rate for patented pharmaceuticals and associated ingredients shall be 15 percent for products of the European Union, the sum of the column 1 duty rate and the additional duty being that rate; generic pharmaceuticals are not subject to tariffs pursuant to section 232 at this time; effective 31 July 2026 for the companies listed in Annex III and 29 September 2026 for other companiesU.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
-
3004.90.92.71
Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Medicaments primarily affecting the eyes, ears, or respiratory system, Other, Containing albuterol sulfate
- General rate
- Free
- From the EU
- 0.0% or 15.0%† Depends on a question US headings applied: 9903.04.62, 9903.05.86 Section 232 pharmaceuticals, Proclamation 11020 of 2 April 2026 (91 FR 18183) clauses (3)(c), (4), (5) and (7), heading 9903.04.62 of subchapter III of chapter 99 with U.S. note 40(c) and (f): the rate for patented pharmaceuticals and associated ingredients shall be 15 percent for products of the European Union, the sum of the column 1 duty rate and the additional duty being that rate; generic pharmaceuticals are not subject to tariffs pursuant to section 232 at this time; effective 31 July 2026 for the companies listed in Annex III and 29 September 2026 for other companiesU.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
-
3004.90.92.72
Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Medicaments primarily affecting the eyes, ears, or respiratory system, Other, Containing timolol maleate
- General rate
- Free
- From the EU
- 0.0%† Estimated from published US measures US headings applied: 9903.05.86 U.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
-
3004.90.92.73
Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Medicaments primarily affecting the eyes, ears, or respiratory system, Other
- General rate
- Free
- From the EU
- 0.0% or 15.0%† Depends on a question US headings applied: 9903.04.62, 9903.05.86 Section 232 pharmaceuticals, Proclamation 11020 of 2 April 2026 (91 FR 18183) clauses (3)(c), (4), (5) and (7), heading 9903.04.62 of subchapter III of chapter 99 with U.S. note 40(c) and (f): the rate for patented pharmaceuticals and associated ingredients shall be 15 percent for products of the European Union, the sum of the column 1 duty rate and the additional duty being that rate; generic pharmaceuticals are not subject to tariffs pursuant to section 232 at this time; effective 31 July 2026 for the companies listed in Annex III and 29 September 2026 for other companiesU.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
-
3004.90.92.74
Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Containing heparin sodium or its salts
- General rate
- Free
- From the EU
- 0.0%† Estimated from published US measures US headings applied: 9903.05.86 U.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
-
3004.90.92.75
Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Containing zoledronic acid or its salts
- General rate
- Free
- From the EU
- 0.0%† Estimated from published US measures US headings applied: 9903.05.86 U.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
-
3004.90.92.76
Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other
- General rate
- Free
- From the EU
- 0.0% or 15.0%† Depends on a question US headings applied: 9903.04.62, 9903.05.86 Section 232 pharmaceuticals, Proclamation 11020 of 2 April 2026 (91 FR 18183) clauses (3)(c), (4), (5) and (7), heading 9903.04.62 of subchapter III of chapter 99 with U.S. note 40(c) and (f): the rate for patented pharmaceuticals and associated ingredients shall be 15 percent for products of the European Union, the sum of the column 1 duty rate and the additional duty being that rate; generic pharmaceuticals are not subject to tariffs pursuant to section 232 at this time; effective 31 July 2026 for the companies listed in Annex III and 29 September 2026 for other companiesU.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
Anti-dumping and countervailing duties, US import taxes and customs fees are not included.
The descriptions above are the US tariff texts, which the United States publishes in English only.
Source: the US International Trade Commission's Harmonized Tariff Schedule (hts.usitc.gov), public domain, and the measures published in the Federal Register.
This is a planning estimate from the US Harmonized Tariff Schedule (revision shown) and the published Federal Register measures as of the date shown, for a shipment of EU origin. It is not a customs entry, legal advice or a broker's opinion, and tariffs.help is not a US-licensed customs broker. The US importer of record or their broker confirms the classification, origin, value and the duty due before filing.
Before you use the code
Check the facts that sit outside the code
The code can be right while what you pay still changes, because of where the goods come from, when they arrive, or extra EU measures.
- The product and its form Check that your product really matches this description, including what it is made of and the form it arrives in.
- Country of origin Trade agreements, sanctions and extra measures can change the treatment of the very same code.
- Current tariff measures Check today's rate, any restrictions or licences, and the quantity customs asks for, with Toldstyrelsen or TARIC.
On an import declaration
3004 90 00 00
When these goods are imported into the EU, the declaration uses the 10-digit form 3004900000: this code with 00 added. There is no further split under it.
Exports from the EU and Intrastat normally use the 8-digit code as it is.
EU tariff data of Sept. 13, 2026.
Rates, origin and documents
Read the signals first. Open only the ones you want to check.
Besides the ordinary duty, the EU records these kinds of measure against this code. They are listed as signals only: whether one applies to your goods can depend on where they come from, who produced them, the exact product and the documents you present. No amounts are worked out here.
Data of Sept. 1, 2026
Lower duty for goods from some countries
Possible
Preferential rates exist for goods originating in:
- Andorra
- San Marino
- Türkiye
- European Union
- Western Sahara
- Switzerland
- Algeria
- Faroe Islands
- +10 origins
These rates apply to OCTs (Overseas Countries and Territories).
Whether you can use one depends on the origin rules for the goods and on the documentation you can show.
Check this code in the official EU TARIC database
Restrictions and paperwork
Important
Import restrictions are recorded for goods originating in:
- Ukraine
- any country
The EU records document conditions on this code. What customs may ask for depends on where the goods come from, exactly what the product is and the customs procedure.
Proof of origin 2 conditions
If you claim a lower rate for goods from a country the EU has a trade agreement with, customs asks for proof of origin, for example a EUR.1 certificate or an origin declaration.
Show the EU's own wording for these conditions
- Movement certificate EUR.1
- Invoice declaration or origin declaration made out by any exporter on invoice or any other commercial document
Sanctions and restricted regions 2 conditions
Some conditions come from EU sanctions rules. They matter when the goods are linked to a country or region the EU restricts trade with.
Show the EU's own wording for these conditions
- Goods not originating from or destined to Crimea or Sevastopol (Articles 2 and 2b.1 of Council Regulation (EU) No 692/2014)
- Goods not originating from or not destined for the non-government controlled areas of Ukraine in the oblasts of Donetsk, Kherson, Luhansk and Zaporizhzhia
Product controls and permits 10 conditions
Depending on the exact product, customs may ask for a licence, a permit or a control certificate before the goods are released.
Show the EU's own wording for these conditions
- Compliance with the REACH restrictions defined in Column 2 of Annex XVII of Regulation (EC) No 1907/2006
- Exemption from REACH restrictions by virtue of Article 67(1) and 67(2) of Regulation (EC) No 1907/2006
- Substance/mixture not subjected to the provisions of Regulation (EC) No 1907/2006 (Annex XVII)
- Presentation of the required "CITES" certificate
- Declared goods do not belong to the Washington Convention (CITES)
- Exemption from the presentation of a valid licence to the customs authorities for the import or exports of products and equipment that are personal effects (Article 22(1), second subparagraph of Regulation (UE) 2024/573)
- Copy of the declaration of conformity - Option A, as referred to in Article 1.2 and in the Annex of Regulation (EU) 2025/2155
- Copy of the declaration of conformity - Option B, as referred to in Article 1.2 and in the Annex of Regulation (EU) 2025/2155
- Copy of the declaration of conformity - Option C, as referred to in Article 1.2 and in the Annex of Regulation (EU) 2025/2155
- Written notification of import and document giving evidence where the products were acquired (seal product)
Statements that the goods are outside a rule's scope 1 condition
Some conditions are statements that a rule does not cover the goods, for example that the product is not on a controlled list.
Show the EU's own wording for this condition
- Goods other than those falling under the applicable provisions of Regulation (EU) 2024/573
Other conditions 9 conditions
These conditions match none of the groups above. Whether customs asks for one depends on the goods, where they come from and the customs procedure.
Show the EU's own wording for these conditions
- Undertaking registered in the F-Gas Portal according to Article 20 of Regulation (EU) 2024/573
- Undertaking importing less than 10 tonnes of CO₂ equivalent of hydrofluorocarbons, per year, contained in equipment or products, exempted from the provisions of Article 19 of Regulation (EU) 2024/573 (Article 19.6 of Regulation (EU) 2024/573)
- Quota provisions from Article 19 (Reg 2024/573) do not apply for products or equipment pre-charged with fluorinated greenhouse gases other than HFCs from Section 1 of Annex I (Reg 2024/573)
- Tonnes of CO₂ equivalent of bulk gases and of gases contained in products or equipment, and parts thereof
- Metered dose inhalers labelling according to the provisions of Article 12 of Regulation (EU) 2024/573, submitted to special approval by the European Medicines Agency or national authorities - See footnote CD807
- Net mass of fluorinated greenhouse gases charged in products and equipment
- Attesting Document (seal product), issued by a recognised body in accordance with Regulation (EU) No 737/2010 prior to 18 October 2015
- Other goods than those seal products mentioned in Regulation (EU) 2015/1850 (OJ L 271)
- European Union - Attesting document for seal products resulting from hunt by Inuit or other indigenous communities for placing on the Union's market in accordance with Article 3 (1) of Regulation (EC) No 1007/2009 on trade in seal products
One last classification check
Check the path and the nearest alternatives.
Use this view if you are still unsure the code describes the product precisely.
Show the steps
Subheading 3004 90 has only this one 8-digit code, so there is no neighbour to compare with.
Worth comparing
Codes that sit close to this one, for when the material itself could be different.
Similar products elsewhere in the tariff
- 3003 39 00 Medicaments containing hormones or steroids used as hormones, not containing antibiotics, not in measured doses or put up for retail sale (excl. those containing insulin) Duty free*
- 3003 49 00 Medicaments containing alkaloids or derivatives thereof, not containing hormones, steroids used as hormones or antibiotics, not in measured doses or put up for retail sale (excl. containing ephedrine, pseudoephedrine "INN", norephedrine or their salts) Duty free*
- 3003 90 00 Medicaments consisting of two or more constituents mixed together for therapeutic or prophylactic uses, not in measured doses or put up for retail sale (excl. antibiotics containing hormones or steroids used as hormones, but not containing antibiotics, alkaloids or derivatives thereof, hormones, antibiotics, antimalarial active principles or goods of heading 3002, 3005 or 3006) Duty free*
- 3003 20 00 Medicaments containing antibiotics, not in measured doses or put up for retail sale (excl. medicaments containing penicillins or derivatives thereof with a penicillanic acid structure, or streptomycins or derivatives thereof) Duty free*
- 3003 10 00 Medicaments containing penicillins or derivatives thereof with a penicillanic acid structure, or streptomycins or derivatives thereof, not in measured doses or put up for retail sale Duty free*
Often confused with
-
3003 39 00
Medicaments containing hormones or steroids used as hormones, not containing antibiotics, not in measured doses or put up for retail sale (excl. those containing insulin)
Duty free*
This code covers medicines containing hormones or hormone-used steroids that are not dosed or in retail packaging; the present code covers dosed or retail-packaged medicines and excludes those ingredients.
-
3003 49 00
Medicaments containing alkaloids or derivatives thereof, not containing hormones, steroids used as hormones or antibiotics, not in measured doses or put up for retail sale (excl. containing ephedrine, pseudoephedrine "INN", norephedrine or their salts)
Duty free*
This code covers medicines containing alkaloids or their derivatives that are not dosed or in retail packaging; the present code covers dosed or retail-packaged medicines and excludes alkaloids.
-
3003 90 00
Medicaments consisting of two or more constituents mixed together for therapeutic or prophylactic uses, not in measured doses or put up for retail sale (excl. antibiotics containing hormones or steroids used as hormones, but not containing antibiotics, alkaloids or derivatives thereof, hormones, antibiotics, antimalarial active principles or goods of heading 3002, 3005 or 3006)
Duty free*
This code covers medicines made from at least two products or mixed ingredients that are not dosed or in retail packaging; the present code covers dosed or retail-packaged medicines.
Duty rates shown here are estimates, read from official EU / Danish, Norwegian and UK tariff data for orientation only. Confirm the current rate with Toldstyrelsen, TARIC, Norwegian Customs or the UK Online Trade Tariff before you file. The rate you pay can also depend on the country of origin. These are base customs duties only: import VAT, excise duties, anti-dumping duties and safeguard or quota measures are not included.
Save codes to your own collection
Create a free account to keep the customs codes you care about in one place, and come back to them whenever you need them.